Wellington Management Group
DRUG

Wellington Management Group’s Bright Minds Biosciences DRUG Stock Holding History

Wellington Management Group’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.97M Buy
136,677
+122,989
+899% +$9.9M ﹤0.01% 1239
2025
Q4 		$1.07M Buy
+13,688
New +$915K ﹤0.01% 1706

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wellington Management Group's DRUG Position: Q1 2026 in Review

Wellington Management Group increased its Bright Minds Biosciences (DRUG) stake by 899% in Q1 2026, buying an estimated $9.9M and bringing the position to 136,677 shares worth $9.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

Wellington Management Group first reported a position in DRUG in Q4 2025 and has held it in 2 quarters since. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Wellington Management Group held 136,677 shares of Bright Minds Biosciences worth $9.97M as of Q1 2026.
  • Wellington Management Group bought 122,989 Bright Minds Biosciences shares in Q1 2026, an estimated $9.9M.
  • Bright Minds Biosciences made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1239 holding.
  • Wellington Management Group first reported a position in Bright Minds Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.